Mirae Asset Global Investments’s Alaunos Therapeutics TCRT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,097
| Closed | -$401K | – | 2446 |
|
|
2022
Q1 | $401K | Sell |
4,097
-729
| -15% | -$71.4K | ﹤0.01% | 1488 |
|
|
2021
Q4 | $789K | Buy |
4,826
+947
| +24% | +$155K | ﹤0.01% | 1355 |
|
|
2021
Q3 | $1.06M | Buy |
3,879
+726
| +23% | +$198K | ﹤0.01% | 1278 |
|
|
2021
Q2 | $1.25M | Buy |
+3,153
| New | +$1.25M | ﹤0.01% | 1191 |
|
|
2021
Q1 | – | Sell |
-1,646
| Closed | -$622K | – | 1608 |
|
|
2020
Q4 | $622K | Buy |
1,646
+435
| +36% | +$164K | ﹤0.01% | 1256 |
|
|
2020
Q3 | $458K | Buy |
1,211
+375
| +45% | +$142K | ﹤0.01% | 1211 |
|
|
2020
Q2 | $411K | Buy |
836
+357
| +75% | +$176K | ﹤0.01% | 1208 |
|
|
2020
Q1 | $176K | Buy |
479
+53
| +12% | +$19.5K | ﹤0.01% | 1340 |
|
|
2019
Q4 | $301K | Buy |
426
+89
| +26% | +$62.9K | ﹤0.01% | 1349 |
|
|
2019
Q3 | $217K | Buy |
337
+249
| +283% | +$160K | ﹤0.01% | 1369 |
|
|
2019
Q2 | $77K | Buy |
+88
| New | +$77K | ﹤0.01% | 1384 |
|